Next Article in Journal
Minocycline/Amoxicillin-Based Bismuth Quadruple Therapy for Helicobacter pylori Eradication: A Pilot Study
Previous Article in Journal
Phenotypic Antimicrobial Resistance Profiles of Human Campylobacter Species Isolated in Northwest Italy, 2020–2023
 
 
Article
Peer-Review Record

Relationship between the Viral Load in Patients with Different COVID-19 Severities and SARS-CoV-2 Variants

Microorganisms 2024, 12(3), 428; https://doi.org/10.3390/microorganisms12030428
by Andrea Santos Coy-Arechavaleta 1,2, Julio Elias Alvarado-Yaah 2, Luis Antonio Uribe-Noguez 2, Francisco Xavier Guerra-Castillo 3, Clara Esperanza Santacruz-Tinoco 4, Eva Ramón-Gallegos 1, José Esteban Muñoz-Medina 4,* and Larissa Fernandes-Matano 4,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Microorganisms 2024, 12(3), 428; https://doi.org/10.3390/microorganisms12030428
Submission received: 20 January 2024 / Revised: 5 February 2024 / Accepted: 8 February 2024 / Published: 20 February 2024
(This article belongs to the Section Virology)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

Coy-Arechavaleta et al. have assessed associations of SARS-CoV-2 viral loads with clinical and epidemiological parameters based on a large Mexican dataset. Although the experience is interesting, I have a few recommendations on how the work could be further improved.

1.) Although I am not a native English speaker myself, partly very long sentences (both in the abstract and in the main text) make this manuscript difficult to read. The authors should consider splitting some sentences to make the manuscript text more idiomatic.

2.) Methods chapter, study design and figure 1) The authors should explain more explicitly what they mean with the term “outliers” (line 89 and figure 1).

3.) Methods chapter, line 160: Not all readers will be well familiar with the double-delta-Ct method for quantification purposes. Although the authors provide a reference on this method in the discussion, a more detailed explanation of the approach would be helpful here.

4.) I strongly recommend for the implementation of a limitations paragraph at the end of the discussion, in which the authors summarize the limitations of the interpretability of their results to the readers. At the very least, the COVID-19 associated uncertainties regarding infection timepoint and symptom-onset should be mentioned, as the associated variability can negatively interfere with the estimations of infection stages.

5.) Discussion, lines 346-350: It seems that two sentences have been erroneously merged here.

Author Response

For research article

Relationship between the viral load in patients with different COVID-19 severities and SARS-CoV-2 variants

 

Response to Reviewer 1 Comments

 

1. Summary

 

 

Thank you very much for taking the time to review this manuscript. Please find the detailed responses below and the corresponding revisions/corrections highlighted/in track changes in the re-submitted files.

 

2. Questions for General Evaluation

Reviewer’s Evaluation

Response and Revisions

Does the introduction provide sufficient background and include all relevant references?

Can be improved

The responses were given in the comments.

Are all the cited references relevant to the research?

Yes

 

Is the research design appropriate?

Yes 

 

Are the methods adequately described?

Can be improved

The responses were given in the comments.

Are the results clearly presented?

Yes

 

Are the conclusions supported by the results?

Can be improved

The responses were given in the comments.

3. Point-by-point response to Comments and Suggestions for Authors

Comments 1: Although I am not a native English speaker myself, partly very long sentences (both in the abstract and in the main text) make this manuscript difficult to read. The authors should consider splitting some sentences to make the manuscript text more idiomatic.

Response 1: We adjusted the text in several parts in a general way, according to the reviewer's suggestion.

Comments 2: Methods chapter, study design and figure 1) The authors should explain more explicitly what they mean with the term “outliers” (line 89 and figure 1).

Response 2: The text was modified to include more detailed information about outliers excluded from the study: “Thereafter, 104 samples with outlier Ct values were identified using the interquartile range (IQR) (samples with the Ct value 3 times the interquartile range value below quartile 1 or above quartile 3). Because these samples contained a Ct value that was numerically distant from the rest of the data, which could lead to misleading results, we decided to exclude these samples, leaving a total of 16,880 included for the analysis carried out in this study.”

Comments 3: Methods chapter, line 160: Not all readers will be well familiar with the double-delta-Ct method for quantification purposes. Although the authors provide a reference on this method in the discussion, a more detailed explanation of the approach would be helpful here.

Response 3: Since we decided to only use ΔCT averages and never reported the increases between groups (ΔΔCT) as such, we decided to modify the nomenclature of the Y axes of the images. With these modifications, the description remains more faithful to what was analyzed. We added a text in the methodology to give more detailed information about the relative quantification method used and how we report the data obtained: “The 2-ΔΔCT method, better known as ΔΔCT, is a relative quantification strategy for the results of a qPCR or RT-qPCR, which uses the generated threshold cycle (CT), assuming an amplification efficiency of 100% in the analyzed samples. The two "deltas" present in the name of this method refer to the fact that the expression level of a target sample is compared to a control or reference sample, also using a reference gene as a normalizer. The results of this method are usually reported in increments from one sample to the other; however, in this work, we only subtract the CT of the endogenous gene (RP) from the CT of amplification of the RdRP gene of SARS-CoV-2. Subsequently, using the resulting CT of each sample (ΔCT), we analyzed the means for comparisons between groups. The ΔCT values shown are inversely proportional to the SARS-CoV-2 viral load.”

In many works, the results of this method are reported in increments of expression of a problem sample compared to a control sample. However, in this study, the amplification CT of the endogenous gene was subtracted from the amplification CT of the RdRP gene of SARS-CoV-2, to eliminate any bias related to sample collection.

Comments 4:  I strongly recommend for the implementation of a limitations paragraph at the end of the discussion, in which the authors summarize the limitations of the interpretability of their results to the readers. At the very least, the COVID-19 associated uncertainties regarding infection timepoint and symptom-onset should be mentioned, as the associated variability can negatively interfere with the estimations of infection stages.

Response 4: We add the following paragraph at the end of the discussion according to the reviewer's suggestion: “Although in this study we analyzed a large amount of data, some variants such as Delta and Omicron had a lot of data, however some others such as Alpha, Beta, Lambda or Mu do not have enough data, the same thing happened with the age groups, the groups from 20 to 59 or over 60 had much more data than the groups from 0 to 9, or from 10 to 19, so it would have been interesting to have a greater number of data from the groups mentioned above. Also there are a large number of variables that can influence the viral load, although in this work we take into account a large number of variables, we do not include the symptoms or comorbidities of each patient.”

 

Comments 5:  Discussion, lines 346-350: It seems that two sentences have been erroneously merged here.

Response 5: The paragraph was rewritten: “… although, we must consider that in their study, the sample was composed of only 286 individuals. Similarly, Liu et al also concluded that patients with severe COVID-19 tend to have a high viral load and a long virus shedding period [31]. Contradictions in results found in the literature may be due to differences in study design and timing of sample collection. Another example of the diversity of published results and conclusions is that some studies have reported that viral load is not related to patient outcome [15,18] or that it is independently correlated with the risk of hospital mortality [32]. Killingley and collaborators [16] conducted a controlled study, inoculating 36 people who had not been in contact with the virus or previously vaccinated, concluding that there is no relationship between viral load and patient outcome. Although these authors were able to control for many of the confounding factors that could affect the results of their study, their n was very small, so we emphasize the need to conduct larger scale studies to shed more light on this issue.”

 

 

 

 

 

 

 

 

 

 

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

More than 16,800 samples taken from the Mexican population with the confirmed COVID-19 cases were studied and the relationship between the viral load of these samples and different demographic and disease variables were analyzed in this article.

Several suggestions

1.      Line 88, please define briefly about [ddCt].

2.      [RNaseP (RP)] not [RP] in line 114. [RP] not [RNaseP (RP)] in line 146.

3.      Lines 151 and 157, [1010] or [1010]?

4.      Please add a reference after lines 154 and 164.

5.      Line 214, please check [not significant differences were found in none of the Groups].

6.      Line 295, [different PCR]?

7.      Line 296, [vaccination time]?

8.      Line 315, it is better to use [spike] than [S].

9.      Line 315, [higher transmission] or [higher replication]?

10.  If the results regarding anti-SARS-CoV2 therapy are available in these subjects, it is better to include the relationship between anti-viral effect and viral load, viral variants in this study.

 

 

Comments on the Quality of English Language

English editing is suggested: [a] The paragraph from lines 47 to 54 is similar to that from 55 to 60; [b] Lines from 225 to 228; [c] Lines from 346 to 349.

Author Response

For research article

Relationship between the viral load in patients with different COVID-19 severities and SARS-CoV-2 variants

 

Response to Reviewer 2 Comments

 

1. Summary

 

 

Thank you very much for taking the time to review this manuscript. Please find the detailed responses below and the corresponding revisions/corrections highlighted/in track changes in the re-submitted files.

 

2. Questions for General Evaluation

Reviewer’s Evaluation

Response and Revisions

Does the introduction provide sufficient background and include all relevant references?

Yes

 

Are all the cited references relevant to the research?

Yes

 

Is the research design appropriate?

Yes 

 

Are the methods adequately described?

Can be improved

The responses were given in the comments.

Are the results clearly presented?

Can be improved

The responses were given in the comments.

Are the conclusions supported by the results?

Yes

 

3. Point-by-point response to Comments and Suggestions for Authors

Comments 1: Line 88, please define briefly about [ddCt].

Response 1: As we decided to use ΔCT averages and never reported the increases between groups (ΔΔCT), we decided to modify the nomenclature of the Y axes of the images. With these modifications, the description remains more faithful to what we analyzed. We added a text in the methodology to give more detailed information about the relative quantification method used and how we report the data obtained: “The 2-ΔΔCT method, better known as ΔΔCT, is a relative quantification strategy for the results of a qPCR or RT-qPCR, which uses the generated threshold cycle (CT), assuming an amplification efficiency of 100% in the analyzed samples. The two "deltas" present in the name of this method refer to the fact that the expression level of a target sample is compared to a control or reference sample, also using a reference gene as a normalizer. The results of this method are usually reported in increments from one sample to the other; however, in this work, we only subtract the CT of the endogenous gene (RP) from the CT of amplification of the RdRP gene of SARS-CoV-2. Subsequently, using the resulting CT of each sample (ΔCT), we analyzed the means for the comparisons between the groups. The ΔCT values ​​shown are inversely proportional to the SARS-CoV-2 viral load."

Comments 2: [RNaseP (RP)] not [RP] in line 114. [RP] not [RNaseP (RP)] in line 146.

Response 2: The changes that were requested have been made.

Comments 3: Lines 151 and 157, [1010] or [1010]?

Response 3: Following the reviewer's observation, the value “1010” was corrected to “1010”.

Comments 4: Please add a reference after lines 154 and 164.

Response 4: We added the requested references. 

Comments 5: Line 214, please check [not significant differences were found in none of the Groups].

Response 5: The text of the mentioned line has been modified: “However, no statistically significant differences were found in any of the Groups, as shown in Figure S1.”

Comments 6: Line 295, [different PCR]?

Response 6: The correction has been made based on the observation of the reviewer:

“Other studies also showed similar results, with the viral load decreasing as the disease progressed [16,20–22], even though the sample collection and diagnostic method were different.”

Comments 7: Line 296, [vaccination time]?

Response 7: The correction has been made based on the observation of the reviewer.

“For this reason, all analyses in this study were performed independently for groups formed with respect to the time between the onset of symptoms and collection of the sample (A, B, C, and D).”

Comments 8: Line 315, it is better to use [spike] than [S].

Response 8: After reviewing another comment, the mentioned line was excluded from the manuscript, therefore the change was no longer necessary.

Comments 9: Line 315, [higher transmission] or [higher replication]?

Response 9: After reviewing the paragraph, the mentioned line was excluded from the manuscript, therefore the clarification was no longer necessary.

Comments 10: If the results regarding anti-SARS-CoV2 therapy are available in these subjects, it is better to include the relationship between anti-viral effect and viral load, viral variants in this study.

Response 10: None of the patients had access to direct antiviral therapy against SARS-CoV-2. During the study period, only palliative therapies were available.

4. Response to Comments on the Quality of English Language

Point 1: English editing is suggested: [a] The paragraph from lines 47 to 54 is similar to that from 55 to 60; [b] Lines from 225 to 228; [c] Lines from 346 to 349.

Response 1:   

a) One of the paragraphs was removed from the manuscript.

b) The paragraph that started at line 225 was rewritten: “As shown in Figure 4, older adults had a lower viral load compared to the other age groups (Group A: 0-9: -5.0734, 10-19: -5.6155; 20-59: -5.3863; ≥60: -4.6224; p <0.05) Group B (0-9: -4.7212, 10-19: -4.8003; 20-59: -4.4685; ≥60: -3.9526; p< 0.05), and the differences were significant only in comparison with the groups of 10-19 and 20-59 years, and only during the first four days after the onset of symptoms.”

c) The text that was originally written on line 346 has been rewritten: “However, unlike our results, Tsukagoshi and collaborators [30] found that the viral load in deceased patients was significantly higher; however, we must consider that in their study, the sample was composed of only 286 individuals. Similarly, Liu et al also concluded that patients with severe COVID-19 tend to have a high viral load and a long virus shedding period [31].”

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

Comments and Suggestions for Authors

The issues I raised previously have been addressed in this revised manuscript.

Back to TopTop